Table of contents
- Manufacture, marketing and sale
- Guidance on appropriate surveillance under IVDR published
- CHMP proposes changing marketing authorisation status for vaccines
- Daily and weekly news alerts
- New and updated content
- New Practice Note
- Updated Practice Notes
- Dates for your diary
- Trackers
- Useful information
Article summary
This week's edition of Life Sciences weekly highlights includes news that the Medical Device Coordination Group published guidance on appropriate surveillance for the transitional provisions under Article 110 of Regulation (EU) 2017/746 (the In Vitro Diagnostic Medical Devices Regulation (IVDR)) and the Human Medicines Committee proposal to change the conditional marketing authorisations of two coronavirus (COVID-19) vaccines.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial